The Bull Case For Mirum Pharmaceuticals (MIRM) Could Change Following Priority FDA Review Of FOP Drug Zilurgisertib

Mirum Pharmaceuticals recently reported positive pivotal phase II results from the PROGRESS study of zilurgisertib in ...